Stoyanova Lab News
Happy Holidays and New Year from Stoyanova Lab
Many more scientific discoveries to come in 2026!
Exciting News: Francisco Solano is now a PhD candidate
Francisco Solano successfully completed his qualifying exam for his project “Investigating the Functional Role of Trop2 in Bladder Cancer and Evaluating Its Potential as a Urine Molecular Biomarker.” Congratulations!
Excited to Share Our New Publication: CDC7 is a targetable regulator of advanced prostate cancer
Stoyanova Lab is excited to share our new publication in the Science Reports on identifying CDC7 as a targetable regulator of advanced prostate cancer.
Congratulations to Dr. Alifiani B. Hartono, and the team!
Link to publication: https://www.nature.com/articles/s41598-025-29574-2
Exciting News: Reva Patel Receives the Molecular and Medical Pharmacology Undergraduate Research Fellows Award
Reva Patel, an undergraduate student in Dr. Stoyanova’s lab, receives the Molecular and Medical Pharmacology Undergraduate Research Fellows Award from the UCLA Undergraduate Research Center.
Congratulations, Reva!
Exciting News: Shruti Sharma is now a PhD candidate
Shruti Sharma successfully completed her qualifying exam for her project “Developing Novel Trop2-Targeting Antibody-Drug Conjugates for Late-Stage Epithelial Cancers.” Congratulations!
Excited to Share a New Review Article: Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey‐Holden Prostate Cancer Academy Meeting
Stoyanova Lab is excited to share a new review article describing the great science presented and discussed at the 12th Annual 2025 Coffey—Holden Prostate Cancer Academy (CHPCA) Meeting, “Deciphering Resistance: Beyond the Androgen Paradigm,” held at the University of California, Los Angeles (UCLA), Luskin Conference Center, in Los Angeles, CA, from June 19 to 22, 2025.
Many thanks to the Prostate Cancer Foundation!
Link to publication: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pros.70102
Exciting News: Diana Argiles Castillo is now a PhD candidate
Diana Argiles Castillo successfully completed her qualifying exam for her project “ATAD2 is a Potential Therapeutic Target for Advanced Prostate Cancer.” Congratulations!
Exciting news: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for neuroendocrine prostate cancer.
Dr. Shiqin Liu, Assistant Adjunct Professor in the Department of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA, was awarded the Exploration – Hypothesis Development Award from the Department of Defense to create new immune-based treatments for neuroendocrine prostate cancer.
Congratulations, Laura!
